Subsidiary (BVI) Clitina Marketing Limited cash capital injection approved by CHLITINA HOLDING LIMITED BOD
· Issued by Chlitina Holding Ltd.
Close
Today's Information
Provided by: CHLITINA HOLDING LIMITED
SEQ_NO
5
Date of announcement
2022/03/10
Time of announcement
19:40:53
Subject
Subsidiary (BVI) Clitina Marketing Limited cash
capital injection approved by CHLITINA HOLDING LIMITED
BOD
Date of events
2022/03/10
To which item it meets
paragraph 11
Statement
1.Date of the board of directors resolution:2022/03/10
2.Source of capital increase funds:capital increase by cash
3.Whether to adopt shelf registration (Yes, please state issuance period/No):
No.
4.Total monetary value of the issuance and number of shares issued (shares
issued not including those distributed to employees if consisting in
capital increase from earnings or capital surplus):USD2,500,000
5.If adopting shelf registration, monetary value and number of shares
to be issued this time:NA
6.The remaining monetary value and shares after this issuance when
adopting shelf registration:NA
7.Par value per share:USD1
8.Issue price:issued by par value per share
9.Number of shares subscribed for by or allocated to employees:None.
10.Number of shares publicly sold:NA
11.Ratio of shares subscribed by or allotted as stock dividends to existing
shareholders:NA
12.Handling method for fractional shares and shares unsubscripted for by
the deadline:NA
13.Rights and obligations of these newly issued shares:
The rights and obligations of the newly issued common shares are
the same as the existing common shares.
14.Utilization of the funds from the capital increase:
increase of the working capital.
15.Any other matters that need to be specified:
(1)The capital injection flow is as follows: (BVI) Chlitina Holding Limited
→ (BVI) Chlitina Group Limited → (BVI) Chlitina International Limited
→ (BVI) Chlitina Marketing Limited. The capital increase amount does not
reach the threshold set by the TWSE for public disclosure and therefore
will not be announced.
(2)The chairman is authorized by the BoD to handle relevant matters such as
the date of the capital injection.
(3)This case ultimately consists of a working capital injection of
NT$60,000,000 for (BVI) Chlitina Marketing Limited Taiwan Branch and
is intended to help meet Taiwan's operational needs.
(4)(BVI) Chlitina Group Limited, (BVI) Chlitina International Limited, and
(BVI) Chlitina Marketing Limited are all 100%-owned by parent company.
